1477 Results

People

  1. Motzer
    Motzer
  2. Hudis
    Hudis
  3. Aghajanian
    Aghajanian
  4. O'Reilly
    O'Reilly
  5. Kris
    Kris
  6. Scher
    Scher
  7. Panageas
    Panageas
  8. Saltz
    Saltz
  9. Schwartz
    Schwartz
  10. Kelsen
    Kelsen

Groups

  1. Department of Medicine (1039)
  2. Solid Tumor Oncology Division (784)
  3. Hematologic Malignancies, Division of (287)
  4. Survivorship Research (234)
  5. Center for Hematologic Malignancies (216)
  6. Genitourinary Oncology Service (208)
  7. Epidemiology and Biostatistics (194)
  8. Biostatistics Service (169)
  9. Gastrointestinal Oncology Service (160)
  10. Population Sciences Research Program (158)
  1. "fatigue"
Formats
  1. Journal Article (1402)
  2. Review (38)
  3. Research Letter (13)
  4. Editorial (10)
  5. Conference Paper (5)
  6. Guidelines (4)
  7. Correspondence (3)
  8. Book Section (2)
Groups
  1. Department of Medicine (1039)
  2. Solid Tumor Oncology Division (784)
  3. Hematologic Malignancies, Division of (287)
  4. Survivorship Research (234)
  5. Center for Hematologic Malignancies (216)
  6. Genitourinary Oncology Service (208)

More Groups

People
  1. Robert Motzer (85)
  2. Clifford Hudis (49)
  3. Carol Aghajanian (46)
  4. Eileen O'Reilly (46)
  5. Howard Scher (44)
  6. Mark Kris (44)

More People

Years
  1. 2025 (60)
  2. 2024 (132)
  3. 2023 (89)
  4. 2022 (46)
  5. 2021 (33)
  6. 2020 (85)

More Years

Publications
  1. Journal of Clinical Oncology (108)
  2. Clinical Cancer Research (82)
  3. Cancer (63)
  4. Lancet Oncology (50)
  5. Gynecologic Oncology (41)
  6. Annals of Oncology (37)

More Publications

Publishers
  1. Elsevier Inc. (244)
  2. Springer (133)
  3. American Society of Clinical Oncology (114)
  4. Elsevier Science, Inc. (108)
  5. Oxford University Press (101)
  6. American Association for Cancer Research (89)

More Publishers

Results (1477)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CEA-CD3 bispecific antibody cibisatamab with or without atezolizumab in patients with CEA-positive solid tumours: Results of two multi-institutional Phase 1 trials
    Journal Article

    Segal, N. H.; Melero, I.; Moreno, V.; Steeghs, N.; Marabelle, A.; Rohrberg, K.; Rodriguez-Ruiz, M. E.; Eder, J. P.; Eng, C.; Manji, G. A.; more...
    Nature Communications (2024)

    Fulltext@MSK | Save
  • Crenolanib and intensive chemotherapy in adults with newly diagnosed FLT3-mutated AML
    Journal Article

    Wang, E. S.; Goldberg, A. D.; Tallman, M.; Walter, R. B.; Karanes, C.; Sandhu, K.; Vigil, C. E.; Collins, R.; Jain, V.; Stone, R. M.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Salvage ablative radiotherapy for isolated local recurrence of pancreatic adenocarcinoma following definitive surgery
    Journal Article

    Dee, E. C.; Ng, V. C.; O’Reilly, E. M.; Wei, A. C.; Lobaugh, S. M.; Varghese, A. M.; Zinovoy, M.; Romesser, P. B.; Wu, A. J.; Hajj, C.; more...
    Journal of Clinical Medicine (2024)

    Fulltext@MSK | Save
  • Managing potential adverse events during treatment with enfortumab vedotin + pembrolizumab in patients with advanced urothelial cancer
    Review

    Brower, B.; McCoy, A.; Ahmad, H.; Eitman, C.; Bowman, I. A.; Rembisz, J.; Milowsky, M. I.
    Frontiers in Oncology (2024)

    Fulltext@MSK | Save
  • Evaluation of radiology resident well-being at a single institution with a dedicated wellness curriculum
    Journal Article

    Pitman, J.; Atallah, J.; Lu, C.; Verzani, Z.; Schweitzer, A.; Min, R. J.; Belfi, L.
    Clinical Imaging (2024)

    Fulltext@MSK | Save
  • Infrared laser moxibustion for cancer-related fatigue in breast cancer survivors: A randomized controlled trial
    Journal Article

    Mao, H.; Jin, M.; Xie, L.; Mao, N.; Shen, X.; Chen, J.; Chen, X.; Mao, J. J.; Shen, X.
    Breast Cancer Research (2024)

    Fulltext@MSK | Save
  • A medical chart audit to assess endocrinologist perceptions of the burden of endogenous Cushing’s syndrome
    Review

    Page-Wilson, G.; Oak, B.; Silber, A.; Meyer, J.; O’Hara, M.; Geer, E. B.
    Pituitary (2024)

    Fulltext@MSK | Save
  • Pegargiminase plus first-line chemotherapy in patients with nonepithelioid pleural mesothelioma: The ATOMIC-Meso randomized clinical trial
    Journal Article

    Szlosarek, P. W.; Creelan, B. C.; Sarkodie, T.; Nolan, L.; Taylor, P.; Olevsky, O.; Grosso, F.; Cortinovis, D.; Chitnis, M.; Roy, A.; more...
    JAMA Oncology (2024)

    Fulltext@MSK | Save
  • Postradical prostatectomy prostate-specific antigen outcomes after 6 versus 18 months of perioperative androgen-deprivation therapy in men with localized, unfavorable intermediate-risk or high-risk prostate cancer: Results of part 2 of a randomized phase 2 trial
    Journal Article

    McKay, R. R.; Xie, W.; Yang, X.; Acosta, A.; Rathkopf, D.; Laudone, V. P.; Bubley, G. J.; Einstein, D. J.; Chang, P.; Wagner, A. A.; more...
    Cancer (2024)

    Fulltext@MSK | Save
  • Real-world patient experience of pexidartinib for tenosynovial giant-cell tumor
    Journal Article

    Lin, F.; Kwong, W. J.; Pan, I.; Ye, X.; Dai, D.; Tap, W.
    The Oncologist (2024)

    Fulltext@MSK | Save